Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2025
Inhibition of the GSK3β/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitabilityTimothy John Baumgartner, Manuel Silva-Pérez, Zahra Haghighijoo, et al.
BMC Geriatrics|May 21, 2024
Preoperative chemoradiotherapy in older patients with rectal cancer guided by comprehensive geriatric assessment within a multidisciplinary team-a multicenter phase II trialWen-Yang Liu, Yuan Tang, Ning Li, et al.
Breast (Edinburgh, Scotland)|October 21, 2022
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancerXu-Ran Zhao, Yu Tang, Hong-Fen Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2020
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From ChinaShu-Lian Wang, Hui Fang, Chen Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation TherapyDan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
JAMA Network Open|November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical TrialNing Li, Yuan Zhu, Lu-Ying Liu, et al.
BMC Cancer|January 25, 2023
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphomaYu-Ting Zhao, Si-Ye Chen, Xin Liu, et al.
Radiation Oncology (London, England)|November 29, 2023
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark caseYu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, et al.
The Lancet. Haematology|May 5, 2025
Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trialXin-Yue Wang, Xi-Mei Zhang, Liang Wang, et al.
Radiation Oncology (London, England)|December 28, 2022
The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trialWen-Yang Liu, Jin-Ming Shi, Ning Li, et al.
Pageof 30